Medical/Pharmaceuticals

Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma

EAST RUTHERFORD, N.J., July 7, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the American Chemical Society's 2026 Green Chem...

2026-07-07 20:00 2981

HKSH's First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate

Minimises Cardiopulmonary Concerns and Maintains Quality of Life HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as well as head and neck cancers, an...

2026-07-07 19:27 3413

Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases

BIRMINGHAM, England, July 7, 2026 /PRNewswire/ -- Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has closed a GBP£2 million oversubscribed seed financing round led by Empirical Ventures, with p...

2026-07-07 19:07 2440

Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib

SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the closing of its previously announc...

2026-07-07 18:53 3215

Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery

All-atom biomolecular foundation model uses co-folding as the entry point to a scalable drug discovery engine; the release marks a concrete step toward advancing open scientific AI for future biomedical research that benefit patients.  LAGUNA HILLS, Calif. and SHANGHAI, July 6, 2026 /PRNewswire/...

2026-07-07 08:00 3714

ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows

A landmark international study has found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART). LONDON, July 7, 2026 /PRNewswire/ -- Presented at the 42nd Annual Meeting of the European Society of Human...

2026-07-07 07:01 2536

Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight

A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone under...

2026-07-07 06:00 4332

Smarter, Lighter, & Construction-Free: Egg Medical Debuts EggNest® Complete 2.0 for Interventional Labs

MINNEAPOLIS, July 6, 2026 /PRNewswire/ -- Egg Medical , a leader inEnhanced Radiation Protection Devices

2026-07-06 22:12 3263

TMRW Vault® Receives CE Mark Under the European Medical Device Regulation (MDR)

WILMINGTON, Del., July 6, 2026 /PRNewswire/ -- Reprotech today announced that the TMRW Vault® has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, supporting commercialization in the European Union and other international markets that recognize the CE mark.

2026-07-06 21:02 2907

Nexsphere-F™ Clinical Study Published in Radiology, Showing 57% Reduction in Knee Osteoarthritis Pain

SEOUL, South Korea, July 6, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that Radiology, the leading peer-reviewed journal in radiology and medical imaging with an impact factor of 17.6, has published cl...

2026-07-06 21:00 4013

Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, "Focused Discussions on Overseas Out-Licensing Deals"

* Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interest * Following successful Phase 1 clinical results, global discussions on OVM-200 expand * Meetings with over 40 companies, including major pharmaceutical companies, out-licensing now within reac...

2026-07-06 20:30 4747

World's First International Patient Begins Treatment with Newly Approved Solid Tumor CAR-T Therapy at Jiahui International Cancer Center

SHANGHAI, July 6, 2026 /PRNewswire/ -- Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to China's l...

2026-07-06 17:15 3027

Ascletis Submits Two IND Applications to U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

-  ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R and GIPR. -  ASC36_35 FDC demonstrated approximately 51% greater relative body weight reducti...

2026-07-06 08:10 4154

Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics

SHANGHAI and GUANGZHOU, China, July 4, 2026 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. ("Sanyou Bio") and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. ("Baiyunshan Xihe") jointly announced the official signing of a strategic cooperation agreement. This partnership will focus ...

2026-07-04 23:25 6995

Straits Forum | Taiwanese Youth Tells: Six Years Rooted in the Mainland - From Starting a Business to Ringing the Bell at HKEX

XIAMEN, China, July 3, 2026 /PRNewswire/ -- This is a news report by Hong Kong Ta Kung Wen Wei Media Group Limited: The 18th Straits Forum was held on June 13 in Xiamen, Fujian, China. At th...

2026-07-04 16:29 7224

DoH and MIT- Koch Institute Partner to Advance AI-Driven Cancer Research

ABU DHABI, UAE, July 3, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative Cancer Research have announced a strategic collaboration to advance AI-enabled oncology research, translatio...

2026-07-03 18:28 5104

Evangel Hospital Launches "3 Instruments of Peace" Service in Support of Advance Medical Directives Implementation

HONG KONG, July 3, 2026 /PRNewswire/ -- The Advance Medical Directives (AMD) legislation will come into effect on 31 July 2026, allowing adults with mental capacity to express their preferences in advance regarding end-of-life care and life-sustaining treatments. Evangel Hospital welcomes this de...

2026-07-03 16:54 7949

Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage

BASEL, Switzerland and SEOUL, South Korea, July 3, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 2nd that it introduced its data platform business at the 9th Digital Biomarkers in Clinical Trials Summit in Basel, Switzerland, highlighting the potential of its ring-type c...

2026-07-03 16:14 4731

Shanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer

SHANGHAI, July 3, 2026 /PRNewswire/ -- Shanghai SinoUnited Hospital today announced the availability of satricabtagene autoleucel ("satri-cel"), the world's first chimeric antigen receptor (CAR) T-cell therapy approved for the treatment of solid tumors, for eligible patients with Claudin18.2-posi...

2026-07-03 13:36 4982

Nona Biosciences Appoints Dr. Peng Wang as Chief Operating Officer to Advance Platform Capabilities and Drive Operational Excellence

CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Peng Wang as Chief Operating Officer (COO). Dr. Wang will be...

2026-07-03 09:36 3948
1 ... 45678910 ... 648

Week's Top Stories